Author:
Rosenthal Allison C.,Munoz Javier L.,Villasboas J. C.
Abstract
AbstractBackgroundAdvances in understanding of cancer biology, genomics, epigenomics, and immunology have resulted in development of several therapeutic options that expand cancer care beyond traditional chemotherapy or radiotherapy, including individualized treatment strategies, novel treatments based on monotherapies or combination therapy to reduce toxicities, and implementation of strategies for overcoming resistance to anticancer therapy.ResultsThis review covers the latest applications of epigenetic therapies for treatment of B cell, T cell, and Hodgkin lymphomas, highlighting key clinical trial results with monotherapies and combination therapies from the main classes of epigenetic therapies, including inhibitors of DNA methyltransferases, protein arginine methyltransferases, enhancer of zeste homolog 2, histone deacetylases, and the bromodomain and extraterminal domain.ConclusionEpigenetic therapies are emerging as an attractive add-on to traditional chemotherapy and immunotherapy regimens. New classes of epigenetic therapies promise low toxicity and may work synergistically with other cancer treatments to overcome drug resistance mechanisms.Graphical Abstract
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Developmental Biology,Genetics,Molecular Biology
Reference118 articles.
1. Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of non-Hodgkin's lymphoma. Med Sci. 2021;9.
2. Hodgkin lymphoma statistics. American Cancer Society Cancer Statistics Center, 2021. Available at: https://cancerstatisticscenter.cancer.org/?_ga=2.108556481.219238712.1625489148-2120540464.1618477006#!/cancer-site/Hodgkin%20lymphoma. Accessed 13 Aug 2021.
3. Survival rates and factors that affect prognosis (outlook) for non-Hodgkin lymphoma. American Cancer Society, 2022. Available at: https://www.cancer.org/cancer/non-hodgkin-lymphoma/detection-diagnosis-staging/factors-prognosis.html. Accessed 27 Jan 2023.
4. Baudino TA. Targeted cancer therapy: the next generation of cancer treatment. Curr Drug Discov Technol. 2015;12:3–20.
5. Chemotherapy side effects. National Health Service, 2020. Available at: https://www.nhs.uk/conditions/chemotherapy/side-effects/. Accessed 1 Feb 2023.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献